Geode Capital Management’s VectivBio Holding VECT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-41,274
Closed -$696K – 4885
2023
Q2
$696K Buy
41,274
+16,627
+67% +$219K ﹤0.01% 3493
2023
Q1
$212K Buy
24,647
+1,593
+7% +$13.1K ﹤0.01% 4018
2022
Q4
$198K Hold
23,054
– – ﹤0.01% 4111
2022
Q3
$138K Hold
23,054
– – ﹤0.01% 4402
2022
Q2
$124K Hold
23,054
– – ﹤0.01% 4498
2022
Q1
$108K Hold
23,054
– – ﹤0.01% 4637
2021
Q4
$113K Buy
23,054
+5,274
+30% +$26K ﹤0.01% 4695
2021
Q3
$137K Hold
17,780
– – ﹤0.01% 4579
2021
Q2
$207K Buy
+17,780
New +$270K ﹤0.01% 4332

Other funds holding VECT

Geode Capital Management's VECT Position: Q3 2023 in Review

Geode Capital Management sold out of VectivBio Holding (VECT) in Q3 2023, closing a stake of 41,274 shares — an estimated $696K sold.

Geode Capital Management first reported a position in VECT in Q2 2021 and held it in 9 quarters. The position peaked at $696K in Q2 2023. 2 funds tracked by Wall St. Rank hold VECT as of Q3 2023.

  • Geode Capital Management reported no remaining VectivBio Holding position as of Q3 2023 after selling out during the quarter.
  • Geode Capital Management sold 41,274 VectivBio Holding shares in Q3 2023, an estimated $696K.
  • Geode Capital Management first reported a position in VectivBio Holding in Q2 2021 and held it in 9 quarters.
  • Geode Capital Management's VectivBio Holding position peaked at $696K in Q2 2023.
  • 2 funds tracked by Wall St. Rank held VectivBio Holding as of Q3 2023.

Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.